Abstract
This review has been withdrawn because it has been split into the following reviews: 'Long‐acting inhaled bronchodilators for cystic fibrosis' and 'Short‐acting inhaled bronchodilators for cystic fibrosis'.
The editorial group responsible for this previously published document have withdrawn it from publication.
MeSH terms
-
Adrenergic beta-Agonists / therapeutic use*
-
Adult
-
Albuterol / analogs & derivatives
-
Albuterol / therapeutic use
-
Bronchial Hyperreactivity / drug therapy*
-
Bronchial Hyperreactivity / etiology
-
Bronchodilator Agents / therapeutic use*
-
Child
-
Cystic Fibrosis / complications*
-
Humans
-
Ipratropium / therapeutic use
-
Randomized Controlled Trials as Topic
-
Salmeterol Xinafoate / therapeutic use
Substances
-
Adrenergic beta-Agonists
-
Bronchodilator Agents
-
Salmeterol Xinafoate
-
Ipratropium
-
Albuterol